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PROSPECTIVE COMPARISON OF TWO LAPAROSCOPIC VESSEL SEALING DEVICES FOR 
MINIMALLY-INVASIVE ADRENALECTOMY IN DOGS 
 
Introduction  
The advent of energy-based vessel sealing devices (VSDs) has been crucial in the development of 
advanced laparoscopic procedures. Laparoscopic adrenalectomy (LA) was firstly described in 
human medicine in 1992 and has now become the standard of care for adrenal tumors.1 The 
procedure has been previously reported in veterinary literature for excision of non-invasive adrenal 
tumors, and it has shown promising results.2,3,4 Reported advantages over an open technique 
include shorter surgical and hospitalization times, and a low morbidity rate.5 Nonetheless, few data 
are available on the efficacy and safety of different VSDs used for dissection and hemostasis 
during LA. The aim of this study is to compare surgical outcome in a cohort of dogs undergoing LA 
with use of 2 VSDs based on different technologies: an ultrasonic device (Harmonic Scalpel [HS]) 
versus a bipolar device (EnSeal [ES]).  
 
Materials and Methods 
Dogs referred to our practice between February 2014 and June 2017 were prospectively enrolled. 
We included dogs with a unilateral adrenal tumor without vascular invasion into the caudal vena 
cava, as confirmed by preoperative CT. Dogs with distant metastasis were excluded. Signalement, 
clinical signs, results of hematological analyses, results of endocrinologic evaluation, location and 
size of the tumor were recorded. If a pheochromocytoma was suspected, phenoxybenzamine was 
administered preoperatively for 2-3 weeks. Dogs with hyperadrenocorticism received postoperative 
calcium heparin and tapering prednisone for 2 weeks.  
LA was performed with dogs in sternal recumbency.3 Three 5-mm ports were placed in the 
paralumbar fossa and dissection of the adrenal gland and hemostasis were achieved with either 
HS or ES. The excised adrenal tumors were submitted for histopathology. Variables compared 
between groups included: surgical time; intraoperative, perioperative (< 24 hours), and 
postoperative (>24 hours) complications; hospitalization time and perioperative deaths. Minimum 
follow-up time was 6 months.  
For continuous variables, mean value and standard deviation were calculated. Since the low 
number of cases in each group would have precluded a significant comparison, no further 
statistical analysis was performed. Overall Survival time (OST) was calculated. 
 
 
 
 
 
Results 
Ten dogs were enrolled. Mean age was 11  1,63 years, mean weight was 9,51  3,34 Kg. There 
were 3 castrated males and 7 spayed females. Breeds were Beagle, Yorkshire Terrier, Pekinese, 
French Bouledogue, Dachshund, Maltese, Poodle and three mixed-breed. Clinical signs included 
polydipsia and polyuria (n=6), dysorexia, hypotension and seizures (n=3). In 2 dogs with no clinical 
signs, unilateral enlargement of the adrenal gland was noted during routinely abdominal 
ultrasound. Hematological analyses were unremarkable in 3 dogs, while revealed hepatic enzymes 
activity above ranges in 5 dogs, and regenerative anemia in 1 dog. Three dogs received 
preoperative phenoxybenzamine, and 6 dogs were treated with postoperative heparin and tapering 
prednisone.  
Mean diameter of adrenal tumor was 25  4.79 mm. Seven dogs had left adrenal tumors and 3 
dogs had a right mass. Five dogs underwent LA with use of ES and 5 with HS; of the 3 right sided 
neoplasms, 2 were excised with HS and 1 with ES.  
 
EnSeal Group 
Mean surgical time was 86  32.28 minutes. Intraoperative complications occurred in 1 of 5 dogs: 
minor hemorrhage from the phrenicoabdominal artery which was easily controlled with vascular 
clips. Perioperative complication occurred in 2 of 5 dogs, that developed fatal respiratory signs at 
12 and 24 hours, respectively. In both dogs, pulmonary thromboembolism was suspected on the 
basis of clinical signs, hematological and radiological findings. The remaining 3 dogs were 
discharged. Mean hospitalization time was 4.67  0.58 days. No postoperative complications were 
recorded. Histopathology revealed adrenocortical carcinoma in 2 cases, adrenocortical adenoma 
in 2 cases and pheochromocytoma in 1 case. The 2 dogs that died preoperatively had a functional 
adrenocortical tumor (1 carcinoma and 1 adenoma). 
 
Harmonic Group 
Mean surgical time was 97  14 minutes. Intraoperative complications occurred in 4 of 5 dogs and 
included: major hemorrhage from branches of the renal vein in 2 dogs, visibility deterioration due to 
smoke production in 2 dogs, and capsule rupture in 1 dog. The 2 cases of major hemorrhage 
required conversion to an open approach; control of the bleeding was easily achieved after 
conversion and both dogs did not require supportive care for hemodynamic changes. No 
perioperative complications or deaths were recorded in this group. All 5 patients were discharged 
and mean hospitalization time was 4  1 days. One dog was discharged after 5 days and 
developed postoperative fatal respiratory complications after 21 days. Pulmonary 
thromboembolism was suspected. Histopathological evaluation revealed adrenocortical carcinoma 
in 2 dogs, adrenocortical adenoma in 1 dog and pheochromocytoma in 2 dogs. The dog that died 
postoperatively had a functional cortical adenoma. 
 Outcome 
There were no intraoperative deaths. Clinical signs resolved briefly after discharged in all dogs. At 
the end of the study, 6 dogs were alive without signs of recurrence. 1 dog died due to unrelated 
causes at 350 days; at that time, the dog was still free from disease. 3 dogs died due to suspected 
thromboembolism at 12 hours, 24 hours and 21 days respectively. OST was 177 days (range 0-
610 days). 
  
Discussion 
Unilateral LA was successfully performed in 10 dogs with use of 2 different VSDs. VSDs offer 
perceivable advantages during laparoscopic surgery, as they allow for fast and reliable dissection 
and hemostasis without requiring accurate vessel isolation, thus reducing instrument interchange 
and surgical time. The development of VSDs based on different technologies has raised the 
question whether any instrument may offer advantages in specific surgical procedures. In human 
medicine, a few papers have compared efficacy and safety of various VSDs. One study suggested 
that bipolar VSDs may provide shorter surgical time and reduce risk of blood loss in human 
patients undergoing LA.6 Similarly, in our study use of ES appeared to be correlated with shorter 
operating time and fewer hemorrhages compared to HS. Intraoperative complications occurred in 4 
of 5 dogs in the HS group versus 1 of 5 dogs in the ES group. Intraoperative complications 
associated with use of HS were smoke production (n=2), capsule rupture (n=1) and major 
hemorrhage (n=2), which required conversion to an open approach. HS is an ultrasonic VSD which 
seals and cuts tissues with formation of a denatured protein coagulum. Thus, inadequate control of 
the blade may cause accidental damage to adjacent vessel and consequent hemorrhage. 
Furthermore, the vaporization of tissues determines a massive production of smoke that may 
preclude correct visualization of anatomical structures and prolong surgical time.  
On the other hand, ES relies on bipolar energy that melts collagen and elastin in vessel wall and 
forms a permanent seal; dieresis is provided through a blade which is independently controlled by 
the surgeon. Therefore, it offers better control over vessel sealing and was correlated with lower 
incidence of hemorrhage. In our study, only 1 patient in the ES group developed intraoperative 
hemorrhage, that was rapidly controlled and didn’t require conversion. However, ES produces 
higher temperatures and determines a greater lateral thermal spread. In our study, perioperative 
deaths due to thromboembolism occurred in 2 dogs in the ES group; it might be hypothesized that 
lateral thermal spread may damage vascular endothelium thus causing abnormal blood clotting. In 
the HS group, there were no perioperative deaths; nonetheless, 1 dogs died 21 days 
postoperatively due to respiratory complications. However, all dogs that developed fatal 
thromboembolism had a functional adrenocortical tumor, and it is thus difficult to determine 
whether this complication was correlated with VDS employed or with tumor type. 7 
Mean hospitalization time was similar for both groups; although all patients were doing clinically 
well 1-2 days postoperatively, it was decided to prolong hospitalization in order to provide IV 
therapy, especially for those receiving postoperative heparin for functional adrenocortical tumors.   
Results of the present study suggests that ES may be provide shorter surgical time and is more 
reliable in vessel dissection and hemostasis. HS, nonetheless, seems to be correlated with lower 
incidence of perioperative deaths. 
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